Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Human pharmacological activity of a new TLR9 agonist antiviral, CPG 10101 (Actilon)

Human pharmacological activity of a new TLR9 agonist antiviral, CPG 10101 (Actilon). Hepatology The official Journal of the American Association for the Study of Liver Disease. 2004; 40(4):697A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.